Brian Lenz
2014 - ADMA Biologics
In 2014, Brian Lenz earned a total compensation of $647.1K as Chief Financial Officer at ADMA Biologics, a 88% increase compared to previous year.
Compensation breakdown
| Bonus | $123,200 |
|---|---|
| Option Awards | $197,600 |
| Salary | $318,525 |
| Other | $7,800 |
| Total | $647,125 |
Lenz received $318.5K in salary, accounting for 49% of the total pay in 2014.
Lenz also received $123.2K in bonus, $197.6K in option awards and $7.8K in other compensation.
Rankings
In 2014, Brian Lenz's compensation ranked 9,369th out of 13,032 executives tracked by ExecPay. In other words, Lenz earned more than 28.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,369 out of 13,032 | 28th |
Division Manufacturing | 3,523 out of 4,966 | 29th |
Major group Chemicals And Allied Products | 1,195 out of 1,686 | 29th |
Industry group Drugs | 946 out of 1,365 | 31st |
Industry Biological Products, Except Diagnostic Substances | 174 out of 236 | 26th |
Source: SEC filing on April 29, 2016.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2014.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019